Open AccessVildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease
Author(s) -
Mazhar Hussain,
Majeed Babar Mz,
Hussain Ms,
Lubna Akhtar
Publication year - 2016
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.326.11133
Subject(s) - vildagliptin , medicine , fatty liver , dyslipidemia , placebo , body mass index , gastroenterology , endocrinology , obesity , disease , insulin , metformin , pathology , alternative medicine
To determine the effect of Vildagliptin in non-alcoholic, fatty liver disease patients with dyslipidemia.